{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:31:30Z","timestamp":1777984290120,"version":"3.51.4"},"reference-count":70,"publisher":"American Association for Cancer Research (AACR)","issue":"3","funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-111692RB-I00"],"award-info":[{"award-number":["PID2019-111692RB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2022-139598OB-I00"],"award-info":[{"award-number":["PID2022-139598OB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["LABAE19040BLAN"],"award-info":[{"award-number":["LABAE19040BLAN"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008431","name":"Consejer\u00eda de Educaci\u00f3n, Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","award":["CLC\u2013"],"award-info":[{"award-number":["CLC\u2013"]}],"id":[{"id":"10.13039\/501100008431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008431","name":"Consejer\u00eda de Educaci\u00f3n, Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","award":["2017\u2013"],"award-info":[{"award-number":["2017\u2013"]}],"id":[{"id":"10.13039\/501100008431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008431","name":"Consejer\u00eda de Educaci\u00f3n, Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","award":["01"],"award-info":[{"award-number":["01"]}],"id":[{"id":"10.13039\/501100008431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["FPU23\/01177"],"award-info":[{"award-number":["FPU23\/01177"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014064","name":"Universidad de Salamanca","doi-asserted-by":"publisher","award":["FS\/36-2020"],"award-info":[{"award-number":["FS\/36-2020"]}],"id":[{"id":"10.13039\/501100014064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014064","name":"Universidad de Salamanca","doi-asserted-by":"publisher","award":["FS\/13-2023"],"award-info":[{"award-number":["FS\/13-2023"]}],"id":[{"id":"10.13039\/501100014064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008431","name":"Consejer\u00eda de Educaci\u00f3n, Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","award":["20229001881660"],"award-info":[{"award-number":["20229001881660"]}],"id":[{"id":"10.13039\/501100008431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003339","name":"Consejo Superior de Investigaciones Cient\u00edficas","doi-asserted-by":"publisher","award":["JAE-ICU-CC-28"],"award-info":[{"award-number":["JAE-ICU-CC-28"]}],"id":[{"id":"10.13039\/501100003339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Aggressive metastatic cancer remains a major clinical challenge because of the unclear underlying mechanisms and the limited treatment options available. N6-Methyladenosine (m6A) is a reversible modification of RNA that is frequently altered in cancer, and inhibitors targeting regulators of this process have been shown to block tumorigenesis. A better understanding of the role of m6A modifications in driving metastatic properties could help reveal potential strategies to prevent and treat metastasis. In this study, we discovered loss of the m6A writer complex component ZC3H13 as a key regulator of metastatic progression. Co-loss of ZC3H13 together with RB1 and BRCA2 occurred in patients with metastatic prostate cancer. Functional in vitro and in vivo assays demonstrated that ZC3H13 loss changes m6A writer complex activity and target specificity, leading to decreased m6A methylation and increased stability of transcripts that promote migration and invasion. Treatment with FDA-approved m6A demethylase inhibitors effectively reduced the metastatic capabilities of ZC3H13-deficient cells. Together, these findings provide insights into how the m6A writer complex selectively methylates mRNAs, highlight the pathologic consequences of altered writer complex composition in cancer, and reveal therapeutic avenues for patients with metastatic cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>FDA-approved m6A demethylase inhibitors can inhibit metastasis driven by ZC3H13 deficiency, which reduces m6A methylation of select transcripts involved in migration and invasion, providing potential therapeutic options for patients with metastatic cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-24-3975","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T17:40:29Z","timestamp":1760722829000},"page":"622-641","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["<i>ZC3H13<\/i>\n                    Loss Drives Cancer Metastatic Progression by Disrupting m6A RNA Methylation"],"prefix":"10.1158","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3992-5786","authenticated-orcid":false,"given":"\u00d3scar","family":"Monteagudo-Garc\u00eda","sequence":"first","affiliation":[{"name":"1Molecular Mechanisms Program, Centro de Investigaci\u00f3n del C\u00e1ncer and Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas (CSIC)-University of Salamanca, Salamanca, Spain."},{"name":"2Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca (IBSAL), Hospital Universitario de Salamanca, Salamanca, Spain."}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2730-3397","authenticated-orcid":false,"given":"Paz","family":"Nombela","sequence":"additional","affiliation":[{"name":"1Molecular Mechanisms Program, Centro de Investigaci\u00f3n del C\u00e1ncer and Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas (CSIC)-University of Salamanca, Salamanca, Spain."},{"name":"2Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca (IBSAL), Hospital Universitario de Salamanca, Salamanca, Spain."}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5868-6768","authenticated-orcid":false,"given":"\u00c1ngel Carlos","family":"Rom\u00e1n","sequence":"additional","affiliation":[{"name":"3Department of Biochemistry, Molecular Biology and Genetics, University of Extremadura, Badajoz, Spain."}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1138-4492","authenticated-orcid":false,"given":"Vicente","family":"Fern\u00e1ndez-Rodero","sequence":"additional","affiliation":[{"name":"1Molecular Mechanisms Program, Centro de Investigaci\u00f3n del C\u00e1ncer and Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas (CSIC)-University of Salamanca, Salamanca, Spain."},{"name":"2Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca (IBSAL), Hospital Universitario de Salamanca, Salamanca, Spain."}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3058-5631","authenticated-orcid":false,"given":"Berta","family":"Casar","sequence":"additional","affiliation":[{"name":"4Instituto de Biomedicina y Biotecnolog\u00eda de Cantabria (IBBTEC), Consejo Superior de Investigaciones Cient\u00edficas (CSIC) - Universidad de Cantabria, Santander, Spain."}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9659-4613","authenticated-orcid":false,"given":"Devi Prasad","family":"Bhattarai","sequence":"additional","affiliation":[{"name":"5Department of Molecular Biology, Ume\u00e5 University, Ume\u00e5, Sweden."},{"name":"6Wallenberg Centre for Molecular Medicine, Ume\u00e5 University, Ume\u00e5, Sweden."}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1015-9923","authenticated-orcid":false,"given":"Diego","family":"Alonso-L\u00f3pez","sequence":"additional","affiliation":[{"name":"7Bioinformatics Unit, Cancer Research Center (CIC-IBMCC, CSIC\/USAL), Consejo Superior de Investigaciones Cient\u00edficas (CSIC) and University of Salamanca (USAL), Salamanca, Spain."}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5689-5073","authenticated-orcid":false,"given":"Diana","family":"Loa-Mes\u00f3n","sequence":"additional","affiliation":[{"name":"8Animal Research Core Facility, University of Salamanca (USAL), Salamanca, Spain."}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6746-6807","authenticated-orcid":false,"given":"Daniela","family":"Barros-Silva","sequence":"additional","affiliation":[{"name":"9Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto)\/Porto Comprehensive Cancer Center \u2013 Raquel Seruca (Porto.CCC) & CI-IPOP@RISE (Health Research Network), Porto, Portugal."}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3171-4666","authenticated-orcid":false,"given":"Rui","family":"Henrique","sequence":"additional","affiliation":[{"name":"9Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto)\/Porto Comprehensive Cancer Center \u2013 Raquel Seruca (Porto.CCC) & CI-IPOP@RISE (Health Research Network), Porto, Portugal."},{"name":"10Department of Pathology and Molecular Immunology, ICBAS \u2013 School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal."},{"name":"11Department of Pathology, Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal."}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4186-5345","authenticated-orcid":false,"given":"Carmen","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[{"name":"9Cancer Biology & Epigenetics Group, Research Center of IPO Porto (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto)\/Porto Comprehensive Cancer Center \u2013 Raquel Seruca (Porto.CCC) & CI-IPOP@RISE (Health Research Network), Porto, Portugal."},{"name":"10Department of Pathology and Molecular Immunology, ICBAS \u2013 School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal."}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8658-2552","authenticated-orcid":false,"given":"Guido W.","family":"Jenster","sequence":"additional","affiliation":[{"name":"12Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands."}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5363-2525","authenticated-orcid":false,"given":"Elena S.","family":"Martens-Uzunova","sequence":"additional","affiliation":[{"name":"12Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands."}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2374-2045","authenticated-orcid":false,"given":"Francesca","family":"Aguilo","sequence":"additional","affiliation":[{"name":"5Department of Molecular Biology, Ume\u00e5 University, Ume\u00e5, Sweden."},{"name":"6Wallenberg Centre for Molecular Medicine, Ume\u00e5 University, Ume\u00e5, Sweden."}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7352-9392","authenticated-orcid":false,"given":"Sandra","family":"Blanco","sequence":"additional","affiliation":[{"name":"1Molecular Mechanisms Program, Centro de Investigaci\u00f3n del C\u00e1ncer and Instituto de Biolog\u00eda Molecular y Celular del C\u00e1ncer, Consejo Superior de Investigaciones Cient\u00edficas (CSIC)-University of Salamanca, Salamanca, Spain."},{"name":"2Instituto de Investigaci\u00f3n Biom\u00e9dica de Salamanca (IBSAL), Hospital Universitario de Salamanca, Salamanca, Spain."}]}],"member":"1086","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"2026020203072599100_bib1","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"2026020203072599100_bib2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"key":"2026020203072599100_bib3","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1158\/1078-0432.CCR-19-1570","article-title":"Significance of BRCA2 and RB1 co-loss in aggressive prostate cancer progression","volume":"26","author":"Chakraborty","year":"2020","journal-title":"Clin Cancer Res"},{"key":"2026020203072599100_bib4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41556-019-0319-0","article-title":"RNA modifications regulating cell fate in cancer","volume":"21","author":"Delaunay","year":"2019","journal-title":"Nat Cell Biol"},{"key":"2026020203072599100_bib5","first-page":"1233","article-title":"Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase","volume":"3","author":"Bokar","year":"1997","journal-title":"RNA"},{"key":"2026020203072599100_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12943-020-01263-w","article-title":"The role of m6A, m5C and Psi RNA modifications in cancer: novel therapeutic opportunities","volume":"20","author":"Nombela","year":"2021","journal-title":"Mol Cancer"},{"key":"2026020203072599100_bib7","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nchembio.687","article-title":"N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO","volume":"7","author":"Jia","year":"2011","journal-title":"Nat Chem Biol"},{"key":"2026020203072599100_bib8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12943-019-1106-z","article-title":"KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3","volume":"18","author":"Lan","year":"2019","journal-title":"Mol Cancer"},{"key":"2026020203072599100_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/cr.2017.15","article-title":"YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA","volume":"27","author":"Shi","year":"2017","journal-title":"Cell Res"},{"key":"2026020203072599100_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.molcel.2016.01.012","article-title":"Nuclear m(6)A reader YTHDC1 regulates mRNA splicing","volume":"61","author":"Xiao","year":"2016","journal-title":"Mol Cell"},{"key":"2026020203072599100_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"key":"2026020203072599100_bib12","doi-asserted-by":"crossref","first-page":"12626","DOI":"10.1038\/ncomms12626","article-title":"YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex","volume":"7","author":"Du","year":"2016","journal-title":"Nat Commun"},{"key":"2026020203072599100_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism","volume":"21","author":"An","year":"2022","journal-title":"Mol Cancer"},{"key":"2026020203072599100_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","article-title":"METTL14 inhibits hematopoietic stem\/progenitor differentiation and promotes leukemogenesis via mRNA m6A modification","volume":"22","author":"Weng","year":"2018","journal-title":"Cell Stem Cell"},{"key":"2026020203072599100_bib15","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/leu.2014.16","article-title":"WTAP is a novel oncogenic protein in acute myeloid leukemia","volume":"28","author":"Bansal","year":"2014","journal-title":"Leukemia"},{"key":"2026020203072599100_bib16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13046-021-01871-4","article-title":"RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent","volume":"40","author":"Wang","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"2026020203072599100_bib17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature"},{"key":"2026020203072599100_bib18","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1158\/2159-8290.CD-23-0007","article-title":"Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances antitumor immunity","volume":"13","author":"Guirguis","year":"2023","journal-title":"Cancer Discov"},{"key":"2026020203072599100_bib19","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The molecular taxonomy of primary prostate cancer","volume":"163","author":"Cancer Genome Atlas Research Network","year":"2015","journal-title":"Cell"},{"key":"2026020203072599100_bib20","doi-asserted-by":"crossref","first-page":"11428","DOI":"10.1073\/pnas.1902651116","article-title":"Genomic correlates of clinical outcome in advanced prostate cancer","volume":"116","author":"Abida","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026020203072599100_bib21","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","article-title":"Integrative clinical genomics of advanced prostate cancer","volume":"161","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"2026020203072599100_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature11125","article-title":"The mutational landscape of lethal castration-resistant prostate cancer","volume":"487","author":"Grasso","year":"2012","journal-title":"Nature"},{"key":"2026020203072599100_bib23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"2026020203072599100_bib24","doi-asserted-by":"crossref","first-page":"giab080","DOI":"10.1093\/gigascience\/giab080","article-title":"Fusion transcripts and their genomic breakpoints in polyadenylated and ribosomal RNA-minus RNA sequencing data","volume":"10","author":"Hoogstrate","year":"2021","journal-title":"Gigascience"},{"key":"2026020203072599100_bib25","doi-asserted-by":"crossref","first-page":"6320","DOI":"10.1158\/0008-5472.CAN-18-1669","article-title":"CANCERTOOL: a visualization and representation interface to exploit cancer datasets","volume":"78","author":"Cortazar","year":"2018","journal-title":"Cancer Res"},{"key":"2026020203072599100_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"key":"2026020203072599100_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ccr.2005.10.001","article-title":"Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression","volume":"8","author":"Varambally","year":"2005","journal-title":"Cancer Cell"},{"key":"2026020203072599100_bib28","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1172\/JCI20032","article-title":"Gene expression profiling predicts clinical outcome of prostate cancer","volume":"113","author":"Glinsky","year":"2004","journal-title":"J Clin Invest"},{"key":"2026020203072599100_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ng1935","article-title":"Integrative molecular concept modeling of prostate cancer progression","volume":"39","author":"Tomlins","year":"2007","journal-title":"Nat Genet"},{"key":"2026020203072599100_bib30","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1073\/pnas.0304146101","article-title":"Gene expression profiling identifies clinically relevant subtypes of prostate cancer","volume":"101","author":"Lapointe","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026020203072599100_bib31","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2026020203072599100_bib32","doi-asserted-by":"crossref","first-page":"D1334","DOI":"10.1093\/nar\/gkab970","article-title":"OncoDB: an interactive online database for analysis of gene expression and viral infection in cancer","volume":"50","author":"Tang","year":"2022","journal-title":"Nucleic Acids Res"},{"key":"2026020203072599100_bib33","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.eururo.2018.09.002","article-title":"Genomic differences between \u201cprimary\u201d and \u201csecondary\u201d muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy","volume":"75","author":"Pietzak","year":"2019","journal-title":"Eur Urol"},{"key":"2026020203072599100_bib34","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"key":"2026020203072599100_bib35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer","volume":"173","author":"Hoadley","year":"2018","journal-title":"Cell"},{"key":"2026020203072599100_bib36","doi-asserted-by":"crossref","first-page":"e1001046","DOI":"10.1371\/journal.pbio.1001046","article-title":"A user\u2019s guide to the encyclopedia of DNA elements (ENCODE)","volume":"9","author":"The ENCODE Project Consortium","year":"2011","journal-title":"PLoS Biol"},{"key":"2026020203072599100_bib37","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","article-title":"Using clusterProfiler to characterize multiomics data","volume":"19","author":"Xu","year":"2024","journal-title":"Nat Protoc"},{"key":"2026020203072599100_bib38","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat Biotechnol"},{"key":"2026020203072599100_bib39","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/cancers12040771","article-title":"VIRMA-dependent N6-methyladenosine modifications regulate the expression of long non-coding RNAs CCAT1 and CCAT2 in prostate cancer","volume":"12","author":"Barros-Silva","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2026020203072599100_bib40","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.3390\/curroncol30030206","article-title":"Gal-3 protein expression and localization in prostate tumours","volume":"30","author":"Lima","year":"2023","journal-title":"Curr Oncol"},{"key":"2026020203072599100_bib41","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat Biotechnol"},{"key":"2026020203072599100_bib42","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows-Wheeler transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"key":"2026020203072599100_bib43","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","article-title":"Model-based analysis of ChIP-Seq (MACS)","volume":"9","author":"Zhang","year":"2008","journal-title":"Genome Biol"},{"key":"2026020203072599100_bib44","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","article-title":"ChIPseeker: an R\/Bioconductor package for ChIP peak annotation, comparison and visualization","volume":"31","author":"Yu","year":"2015","journal-title":"Bioinformatics"},{"key":"2026020203072599100_bib45","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/bioinformatics\/btt171","article-title":"Exome-based analysis for RNA epigenome sequencing data","volume":"29","author":"Meng","year":"2013","journal-title":"Bioinformatics"},{"key":"2026020203072599100_bib46","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","article-title":"Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities","volume":"38","author":"Heinz","year":"2010","journal-title":"Mol Cell"},{"key":"2026020203072599100_bib47","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s42003-024-06326-y","article-title":"Pan-cancer discovery of somatic mutations from RNA sequencing data","volume":"7","author":"Tang","year":"2024","journal-title":"Commun Biol"},{"key":"2026020203072599100_bib48","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.molcel.2018.02.015","article-title":"Zc3h13 regulates nuclear RNA m(6)A methylation and mouse embryonic stem cell self-renewal","volume":"69","author":"Wen","year":"2018","journal-title":"Mol Cell"},{"key":"2026020203072599100_bib49","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1101\/gad.309146.117","article-title":"Zc3h13\/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15\/Spenito to the m6A machinery component Wtap\/Fl(2)d","volume":"32","author":"Knuckles","year":"2018","journal-title":"Genes Dev"},{"key":"2026020203072599100_bib50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41421-018-0019-0","article-title":"VIRMA mediates preferential m6A mRNA methylation in 3\u2032UTR and near stop codon and associates with alternative polyadenylation","volume":"4","author":"Yue","year":"2018","journal-title":"Cell Discov"},{"key":"2026020203072599100_bib51","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/s41422-022-00725-8","article-title":"Cryo-EM structures of human m6A writer complexes","volume":"32","author":"Su","year":"2022","journal-title":"Cell Res"},{"key":"2026020203072599100_bib52","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tig.2019.12.007","article-title":"Molecular mechanisms driving mRNA degradation by m6A modification","volume":"36","author":"Lee","year":"2020","journal-title":"Trends Genet"},{"key":"2026020203072599100_bib53","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12943-020-01267-6","article-title":"YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer","volume":"19","author":"Li","year":"2020","journal-title":"Mol Cancer"},{"key":"2026020203072599100_bib54","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1042\/BST20230574","article-title":"RNA m6A modification, signals for degradation or stabilisation?","volume":"52","author":"Wei","year":"2024","journal-title":"Biochem Soc Trans"},{"key":"2026020203072599100_bib55","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41416-021-01641-1","article-title":"MYB interacts with androgen receptor, sustains its ligand-independent activation and promotes castration resistance in prostate cancer","volume":"126","author":"Srivastava","year":"2022","journal-title":"Br J Cancer"},{"key":"2026020203072599100_bib56","doi-asserted-by":"crossref","first-page":"102725","DOI":"10.1016\/j.jbc.2022.102725","article-title":"Biphasic transcriptional and posttranscriptional regulation of MYB by androgen signaling mediates its growth control in prostate cancer","volume":"299","author":"Acharya","year":"2023","journal-title":"J Biol Chem"},{"key":"2026020203072599100_bib57","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/nar\/gku1276","article-title":"Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5","volume":"43","author":"Huang","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2026020203072599100_bib58","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejca.2023.02.022","article-title":"Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers","volume":"185","author":"Lozano","year":"2023","journal-title":"Eur J Cancer"},{"key":"2026020203072599100_bib59","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1158\/1541-7786.MCR-21-0014","article-title":"Mapping of m6A and its regulatory targets in prostate cancer reveals a METTL3-low induction of therapy resistance","volume":"19","author":"Cotter","year":"2021","journal-title":"Mol Cancer Res"},{"key":"2026020203072599100_bib60","first-page":"976","article-title":"Knockdown RBM15 inhibits colorectal cancer cell proliferation and metastasis via N6-methyladenosine (m6A) modification of MyD88 mRNA","volume":"37","author":"Zhang","year":"2022","journal-title":"Cancer Biother Radiopharm"},{"key":"2026020203072599100_bib61","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/hep.28885","article-title":"METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6-methyladenosine-dependent primary MicroRNA processing","volume":"65","author":"Ma","year":"2017","journal-title":"Hepatology"},{"key":"2026020203072599100_bib62","doi-asserted-by":"crossref","first-page":"8899","DOI":"10.1002\/jcp.27551","article-title":"ZC3H13 suppresses colorectal cancer proliferation and invasion via inactivating Ras-ERK signaling","volume":"234","author":"Zhu","year":"2019","journal-title":"J Cell Physiol"},{"key":"2026020203072599100_bib63","doi-asserted-by":"crossref","first-page":"1328444","DOI":"10.1155\/2021\/1328444","article-title":"ZC3H13 inhibits the progression of hepatocellular carcinoma through m6A-PKM2-mediated glycolysis and enhances chemosensitivity","volume":"2021","author":"Wang","year":"2021","journal-title":"J Oncol"},{"key":"2026020203072599100_bib64","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jfma.2022.12.019","article-title":"Overexpressed ZC3H13 suppresses papillary thyroid carcinoma growth through m6A modification-mediated IQGAP1 degradation","volume":"122","author":"Xie","year":"2023","journal-title":"J Formos Med Assoc"},{"key":"2026020203072599100_bib65","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10555-023-10153-8","article-title":"From modulation of cellular plasticity to potentiation of therapeutic resistance: new and emerging roles of MYB transcription factors in human malignancies","volume":"43","author":"Anand","year":"2024","journal-title":"Cancer Metastasis Rev"},{"key":"2026020203072599100_bib66","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/carcin\/bgs134","article-title":"Myb overexpression overrides androgen depletion-induced cell cycle arrest and apoptosis in prostate cancer cells, and confers aggressive malignant traits: potential role in castration resistance","volume":"33","author":"Srivastava","year":"2012","journal-title":"Carcinogenesis"},{"key":"2026020203072599100_bib67","doi-asserted-by":"crossref","first-page":"102209","DOI":"10.1016\/j.gde.2024.102209","article-title":"Clinical perspectives in epitranscriptomics","volume":"87","author":"Santos-Pujol","year":"2024","journal-title":"Curr Opin Genet Dev"},{"key":"2026020203072599100_bib68","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","article-title":"Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia","volume":"35","author":"Huang","year":"2019","journal-title":"Cancer Cell"},{"key":"2026020203072599100_bib69","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1038\/s41467-019-10669-0","article-title":"m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade","volume":"10","author":"Yang","year":"2019","journal-title":"Nat Commun"},{"key":"2026020203072599100_bib70","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.celrep.2017.02.059","article-title":"m6A RNA methylation regulates the self-renewal and tumorigenesis of glioblastoma stem cells","volume":"18","author":"Cui","year":"2017","journal-title":"Cell Rep"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-24-3975\/3660804\/can-24-3975.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/3\/622\/3728788\/can-24-3975.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/86\/3\/622\/3728788\/can-24-3975.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T08:07:52Z","timestamp":1770019672000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/86\/3\/622\/771927\/ZC3H13-Loss-Drives-Cancer-Metastatic-Progression"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":70,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,10,17]]},"published-print":{"date-parts":[[2026,2,2]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-24-3975","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.31228590","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.31228596","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.31228584","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.31228587","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.31228581","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.31228605","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.31228614","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.31228623","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.31228599","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.31228602","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.31228611","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.31228629","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.31228608","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.8284908","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]}}}